<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report four patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with isochromosome i(17q) as the sole chromosomal anomaly </plain></SENT>
<SENT sid="1" pm="."><plain>One patient was classified as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) and three as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> four patients shared several features such as male sex, advanced age, severe <z:hpo ids='HP_0001903'>anemia</z:hpo>, as well as a bone marrow with myeloproliferative characteristics: hypercellularity, prominent baso- and <z:hpo ids='HP_0001880'>eosinophilia</z:hpo>, and marked increase of micromegakaryocytes </plain></SENT>
<SENT sid="3" pm="."><plain>We suggest that patients with i(17q) as the sole chromosomal anomaly may identify a distinct <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with characteristics between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>) </plain></SENT>
</text></document>